Laboratory Evaluation for Non-Diabetic Persistent Proteinuria
In a non-diabetic patient with persistent proteinuria, obtain serum creatinine with eGFR calculation, urine microscopy with sediment analysis, and targeted serologic testing based on clinical suspicion to assess kidney injury severity and identify secondary causes. 1, 2
Essential Baseline Laboratory Tests
Renal Function Assessment
- Serum creatinine and eGFR using the CKD-EPI equation must be obtained to stage chronic kidney disease and assess the degree of functional impairment. 1, 3
- Calculate eGFR incorporating age, sex, and race—do not interpret serum creatinine alone, especially in elderly patients, women, or those with low muscle mass where a "normal" creatinine may mask significant renal dysfunction. 2
Urine Sediment Microscopy
- Perform urine microscopy to examine for dysmorphic red blood cells, red cell casts, or white cell casts—these findings strongly suggest glomerular disease and mandate nephrology referral. 1, 2, 3
- The presence of active urinary sediment distinguishes glomerular pathology from tubular or overflow proteinuria and guides the urgency of specialist evaluation. 2, 3
Quantitative Proteinuria Confirmation
- If not already done, confirm proteinuria with a spot urine protein-to-creatinine ratio (UPCR) from a first-morning void—two positive results out of three samples over 3 months defines persistence. 1, 2
- A UPCR ≥200 mg/g indicates pathological proteinuria; values ≥1000 mg/g (moderate range) or ≥3500 mg/g (nephrotic range) carry progressively higher risk and different management implications. 2, 3
Secondary Cause Evaluation—Risk-Stratified Serologic Testing
For All Patients with Persistent Proteinuria
- Hepatitis B and C serologies should be obtained because chronic viral hepatitis causes membranous nephropathy and membranoproliferative glomerulonephritis. 3
- Serum glucose or HbA1c to exclude undiagnosed diabetes, even in patients without known diabetes history. 1, 3
When Clinical Features Suggest Autoimmune Disease
- Antinuclear antibody (ANA) and complement levels (C3, C4) are indicated when systemic lupus erythematosus is suspected—particularly in younger patients, women, or those with constitutional symptoms. 3
- In adolescents with proteinuria, specifically consider lupus nephritis because childhood-onset SLE has higher incidence and more severe renal involvement than adult-onset disease. 2
When Nephrotic-Range Proteinuria is Present (UPCR ≥3500 mg/g)
- Serum albumin to confirm hypoalbuminemia, which defines nephrotic syndrome and triggers thromboprophylaxis decisions. 2
- Serum protein electrophoresis and immunofixation in patients >50 years or with unexplained proteinuria to rule out multiple myeloma and monoclonal gammopathy. 2, 3
- Consider anti-phospholipase A2 receptor (PLA2R) antibody if membranous nephropathy is suspected, as this can guide biopsy decisions. 2
When Hematuria Accompanies Proteinuria
- Screen first-degree relatives' urine for hematuria because benign familial hematuria (thin basement membrane disease) follows autosomal-dominant inheritance. 2
Structural Imaging
- Renal ultrasound should be performed to assess kidney size, rule out obstruction or polycystic disease, and evaluate cortical echogenicity—small echogenic kidneys indicate chronic irreversible injury, while normal-sized kidneys suggest potentially reversible glomerular pathology. 2, 3
Common Pitfalls to Avoid
- Do not order extensive autoimmune panels reflexively—target serologic testing based on clinical suspicion (age, sex, systemic symptoms, urinary sediment findings) to avoid false-positive results and unnecessary cost. 3
- Do not skip urine microscopy—dipstick hematuria alone is insufficient; dysmorphic RBCs and casts are the critical findings that distinguish glomerular from non-glomerular bleeding. 2, 3
- Do not delay nephrology referral while awaiting serologic results if eGFR <30 mL/min/1.73 m², proteinuria >1 g/day persists despite 3–6 months of conservative therapy, or nephrotic-range proteinuria is present. 2, 3